Kiniksa Pharmaceuticals
KNSA
KNSA
127 hedge funds and large institutions have $448M invested in Kiniksa Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 49 increasing their positions, 43 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 132 → 127 (-5)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
Holders
127
Holding in Top 10
1
Calls
$4.47M
Puts
$3.37M
Top Buyers
| 1 | +$9.92M | |
| 2 | +$8.48M | |
| 3 | +$7.32M | |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
+$4.21M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$4.08M |
Top Sellers
| 1 | -$6.78M | |
| 2 | -$4.85M | |
| 3 | -$4.5M | |
| 4 |
Millennium Management
New York
|
-$4.13M |
| 5 |
BlackRock
New York
|
-$3.18M |